Rheumatoid Arthritis, Its Diagnostic Approach and How to treat it
Main Article Content
Abstract
Introduction. Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by symmetrical erosive polyarthritis leading to progressive disability. It is more common in women, with a 3:1 ratio. Environmental risk factors are smoking, exposure to silica and textile dust.
Materials and methods. Fifteen articles and three books on rheumatoid arthritis were chosen to identify the most accurate diagnostic methods and the most effective and innovative treatments.
Discussion. Related autoantibodies, such as rheumatoid factors, anti-citrullinated antibodies and anti- caramylated antibodies can be found in serum long before the disease develops.
The interaction between genetic and environmental factors causes a breakdown of immune tolerance and triggers systemic autoimmunity. It has been shown that the lungs, oral mucosa, and gastrointestinal tract are initial sites where the immune system can become activated and produce RA.
Different imaging techniques are available for diagnosis: plain radiography, Doppler ultrasound, and magnetic resonance imaging. Doppler ultrasound was found to be more sensitive in identifying minimal synovitis and more sensitive than plain radiography in detecting joint erosions. As pharmacological treatment, it has been concluded that the first-line drug is methotrexate, as it relieves signs and symptoms, improves physical function, and prevents or slows the progression of joint damage. We also observed that NSAIDs help in the inflammatory and symptomatic control of RA.
Conclusion. The quality of life of affected patients has been maintained thanks to the early detection of the disease, since there are several treatments (physical therapies, aerobic exercises, medications, etc.), which help to stop the evolution of this disease and thus allow the patient to lead a daily life.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Martínez, F. M. (2015). Traumatology and orthopedics for the medical degree: Vol. 1° (1st ed.) [Electronic book]. Elsevier.
II. Papadakis, M. A., McPhee, S. J. Rabow, M. W. (2020). Clinical diagnosis and treatment: Vol. 1° (6th ed.). Mc.
III. Shanahan, J., Chueco, M., Serrano, H. Lopez, V. (2018). Harrison. Principles of Internal Medicine: Vol. 2° (20th ed.) Chapter 351. McGraw-Hill Education.
IV. Nora Petrovska, Klára Prajzlerová, Jirí Vencovsky, Ladislav Senolt and María Filková. (2021). The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis. 13/03/2022, from Elsevier Website: https://bibliodig.uag.mx:2058/#!/content/journal/1-s2.0-S1568997221000616
V. Ebel, A., & O'Dell, J. (2020). Clinical Features, Diagnosis, and Treatment of Rheumatoid Arthritis. ClinicalKey. https://bibliodig.uag.mx:2058/#!/content/journal/1-s2.0-S2405799120300682
VI. Littlejohn, E., & Monrad, E. (2018). Early Diagnosis and Treatment of Rheumatoid Arthritis. ClinicalKey. https://bibliodig.uag.mx:2058/#!/content/journal/1-s2.0-S0095454318300150
VII. Martínez Téllez G, Torres Rives B, Gómez Morejón JA, Pérez Garay H, Rodríguez AM, Portal Miranda JÁ. Diagnostic value of anti-fibrinogen citrullinated peptide antibodies in rheumatoid arthritis. Rheumatol Clin. 2020;16:455-461.
VIII. DHIRENDRA KUMAR VERMA,PAGSOONAM Kumari, and SUBRAMANI KANAGARAJ. (2022). Engineering Aspects of Incidence, Prevalence, and Management of Osteoarthritis: A Review 26-02-2022, from Department of Mechanical Engineering,
IX. Indian Institute of Technology Guwahati Website:
X. https:// doi.org/10.1007/s10439-022-02913-4
XI. Álvarez, P., Palomo, J., Martínez, M., Corral, F., & Vázquez, M. (2021). Rheumatoid arthritis: treatment. Elsevier. https://www.sciencedirect.com/science/article/pii/S0304541221000858
XII. Wendy Estefanía Armas Rodríguez, Gema Adriana Alarcón Medina, Fernando Daniel Ocampo Dávila, Claudia Maritza Arteaga, Priscila Alexandra Arteaga Paredes. (2019). Rheumatoid arthritis, diagnosis, evolution and treatment. 13/03/2022, from Revista cubana de reumatología Website: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962019000300 013
XIII. Sol Chao, Xuanqi, Yushu Yang, Ling Yan Lei, Lixia Gao, Huifang Guo. (2022). Importance of baseline musculoskeletal ultrasound findings in the prognosis of rheumatoid arthritis. 26-02-2022, from Clinical Rheumatology Website: https://doi.org/10.1007/s10067-021-06017-7
XIV. Yuji Joyo- Yohei Kawaguchi- Hiroki Yonezu - Hiroya Senda - Sanshiro Yasuma. (2022). The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes. 13/03/2022, from Springer Website: https://bibliodig.uag.mx:2068/article/10.1007/s12026-022-09261-4
XV. Cardiel MH, Carrillo S, Pérez M, Andrade L, Pacheco Tena C, Silveira LH, et al. Update of guidelines for the pharmacological treatment of arthritis.
XVI. Rheumatoid Rheumatology of the Mexican College of Rheumatology 2018. Rheumatol Clin. 2021;17:215-228. The constant therapeutic advances in rheumatoid arthritis (RA) make it necessary to periodically review treatment guidelines in order to offer the treating physician updated, evidence-based recommendations adapted to real clinical practice.
XVII. Yoshishige Miyabe, Chie Miyabe, Andrew D. Luster. (2017). LTB4 and BLT1 in inflammatory arthritis. February 20, 2022, from ELSEVIER Website: https://www.sciencedirect.com/science/article/abs/pii/S104453231730091X?vi a%3Dihub.
XVIII. Karin Schölin Bywall, Bente Appel Esbensen, Marta Lasón, María Heidenvall, Inger Erlandson, Jennifer Viberg-Johansson. (2021). Functional capacity vs side effects: treatment attributes to consider when individualizing treatment for patients with rheumatoid arthritis. 26-02-2022, from Clinical Rheumatology Website: https:// doi.org/10.1007/s10067-021-05961-8.